Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 19 for Pulmonary hypertension

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study of Macitentan in Pulmonary Hypertension After Left Ventricular Assist Device Implantation

    Scottsdale/Phoenix, AZ

  2. A Study to Evaluate Whether or Not Selexipag is Effective and Safe in Patients with Chronic Thromboembolic Pulmonary Hypertension when the Disease is Inoperable or Persistent/Recurrent After Surgery

    Jacksonville, FL

  3. A Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension

    Jacksonville, FL

  4. A Study Evaluating the Long-Term Effectiveness and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

    Rochester, MN

  5. A Study to Evaluate the Safety and Tolerability of TreT in Subjects with PAH Currently Using Tyvaso

    Jacksonville, FL

  6. A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

    Rochester, MN

  7. A Study to Evaluate the Safety and Effectiveness of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

    Jacksonville, FL

  8. A Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension

    Rochester, MN

  9. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients

    Jacksonville, FL, Rochester, MN

  10. A Study to Evaluate the Effectiveness and Safety of Ralinepag To Improve Treatment Outcomes in Peripheral Arterial Hypertension (PAH) Patients

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer